English
简体中文
Total: £ 56.28
Published Date: 2025-11-07 | Pages: 138 | Tables: 142 | Medical Care
The global RNA Gene Expression Sequencing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
RNA gene expression sequencing is a high-throughput sequencing technology used to analyze the type and amount of RNA in cells or tissues to understand the expression patterns and levels of genes. Through RNA gene expression sequencing, comprehensive quantitative analysis of the transcriptome can be performed, including identifying the type and number of transcripts, detecting gene expression levels, and discovering new RNA species. This technology is of great significance for studying gene expression regulation, diagnosing diseases and discovering new drug targets.
From a downstream perspective, Biomedical Field accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
RNA Gene Expression Sequencing leading manufacturers including Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific, Azenta, LabCorp, etc., dominate supply; the top five capture approximately % of global revenue, with Illumina leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global RNA Gene Expression Sequencing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Segment by Type
Total RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the RNA Gene Expression Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to RNA Gene Expression Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global RNA Gene Expression Sequencing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Total RNA
1.2.3 Noncoding RNA
1.3 Market Segmentation by Application
1.3.1 Global RNA Gene Expression Sequencing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global RNA Gene Expression Sequencing Revenue Estimates and Forecasts 2020-2031
2.2 Global RNA Gene Expression Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global RNA Gene Expression Sequencing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global RNA Gene Expression Sequencing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Total RNA Market Size by Players
3.3.2 Noncoding RNA Market Size by Players
3.4 Global RNA Gene Expression Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global RNA Gene Expression Sequencing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global RNA Gene Expression Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America RNA Gene Expression Sequencing Market Size by Type (2020-2031)
6.4 North America RNA Gene Expression Sequencing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America RNA Gene Expression Sequencing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe RNA Gene Expression Sequencing Market Size by Type (2020-2031)
7.4 Europe RNA Gene Expression Sequencing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe RNA Gene Expression Sequencing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific RNA Gene Expression Sequencing Market Size by Type (2020-2031)
8.4 Asia-Pacific RNA Gene Expression Sequencing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific RNA Gene Expression Sequencing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America RNA Gene Expression Sequencing Market Size by Type (2020-2031)
9.4 Central and South America RNA Gene Expression Sequencing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America RNA Gene Expression Sequencing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa RNA Gene Expression Sequencing Market Size by Type (2020-2031)
10.4 Middle East and Africa RNA Gene Expression Sequencing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa RNA Gene Expression Sequencing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina RNA Gene Expression Sequencing Product Features and Attributes
11.1.4 Illumina RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.1.5 Illumina RNA Gene Expression Sequencing Revenue by Product in 2024
11.1.6 Illumina RNA Gene Expression Sequencing Revenue by Application in 2024
11.1.7 Illumina RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.1.8 Illumina RNA Gene Expression Sequencing SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific RNA Gene Expression Sequencing Product Features and Attributes
11.2.4 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific RNA Gene Expression Sequencing SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Corporation Information
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad RNA Gene Expression Sequencing Product Features and Attributes
11.3.4 Bio-Rad RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.3.5 Bio-Rad RNA Gene Expression Sequencing Revenue by Product in 2024
11.3.6 Bio-Rad RNA Gene Expression Sequencing Revenue by Application in 2024
11.3.7 Bio-Rad RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.3.8 Bio-Rad RNA Gene Expression Sequencing SWOT Analysis
11.3.9 Bio-Rad Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Corporation Information
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Gene Expression Sequencing Product Features and Attributes
11.4.4 Agilent Technologies RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.4.5 Agilent Technologies RNA Gene Expression Sequencing Revenue by Product in 2024
11.4.6 Agilent Technologies RNA Gene Expression Sequencing Revenue by Application in 2024
11.4.7 Agilent Technologies RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.4.8 Agilent Technologies RNA Gene Expression Sequencing SWOT Analysis
11.4.9 Agilent Technologies Recent Developments
11.5 QIAGEN
11.5.1 QIAGEN Corporation Information
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN RNA Gene Expression Sequencing Product Features and Attributes
11.5.4 QIAGEN RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.5.5 QIAGEN RNA Gene Expression Sequencing Revenue by Product in 2024
11.5.6 QIAGEN RNA Gene Expression Sequencing Revenue by Application in 2024
11.5.7 QIAGEN RNA Gene Expression Sequencing Revenue by Geographic Area in 2024
11.5.8 QIAGEN RNA Gene Expression Sequencing SWOT Analysis
11.5.9 QIAGEN Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview
11.6.3 Roche RNA Gene Expression Sequencing Product Features and Attributes
11.6.4 Roche RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.6.5 Roche Recent Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Corporation Information
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences RNA Gene Expression Sequencing Product Features and Attributes
11.7.4 Pacific Biosciences RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.7.5 Pacific Biosciences Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Gene Expression Sequencing Product Features and Attributes
11.8.4 Eurofins Scientific RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 Azenta
11.9.1 Azenta Corporation Information
11.9.2 Azenta Business Overview
11.9.3 Azenta RNA Gene Expression Sequencing Product Features and Attributes
11.9.4 Azenta RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.9.5 Azenta Recent Developments
11.10 LabCorp
11.10.1 LabCorp Corporation Information
11.10.2 LabCorp Business Overview
11.10.3 LabCorp RNA Gene Expression Sequencing Product Features and Attributes
11.10.4 LabCorp RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Corporation Information
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics RNA Gene Expression Sequencing Product Features and Attributes
11.11.4 BGI Genomics RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.11.5 BGI Genomics Recent Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Corporation Information
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology RNA Gene Expression Sequencing Product Features and Attributes
11.12.4 Zhijiang Biology RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.12.5 Zhijiang Biology Recent Developments
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Corporation Information
11.13.2 Novogene Co., Ltd Business Overview
11.13.3 Novogene Co., Ltd RNA Gene Expression Sequencing Product Features and Attributes
11.13.4 Novogene Co., Ltd RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.13.5 Novogene Co., Ltd Recent Developments
11.14 Macrogen
11.14.1 Macrogen Corporation Information
11.14.2 Macrogen Business Overview
11.14.3 Macrogen RNA Gene Expression Sequencing Product Features and Attributes
11.14.4 Macrogen RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.14.5 Macrogen Recent Developments
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Corporation Information
11.15.2 Tsingke Biotechnology Co., Ltd. Business Overview
11.15.3 Tsingke Biotechnology Co., Ltd. RNA Gene Expression Sequencing Product Features and Attributes
11.15.4 Tsingke Biotechnology Co., Ltd. RNA Gene Expression Sequencing Revenue and Gross Margin (2020-2025)
11.15.5 Tsingke Biotechnology Co., Ltd. Recent Developments
12 RNA Gene Expression SequencingIndustry Chain Analysis
12.1 RNA Gene Expression Sequencing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 RNA Gene Expression Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global RNA Gene Expression Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global RNA Gene Expression Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global RNA Gene Expression Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global RNA Gene Expression Sequencing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global RNA Gene Expression Sequencing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global RNA Gene Expression Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global RNA Gene Expression Sequencing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global RNA Gene Expression Sequencing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Gene Expression Sequencing as of 2024)
Table 11. Global RNA Gene Expression Sequencing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global RNA Gene Expression Sequencing Companies Headquarters
Table 13. Global RNA Gene Expression Sequencing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global RNA Gene Expression Sequencing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global RNA Gene Expression Sequencing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global RNA Gene Expression Sequencing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global RNA Gene Expression Sequencing Revenue by Application (2026-2031) & (US$ Million)
Table 21. RNA Gene Expression Sequencing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
Table 25. North America RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
Table 27. Europe RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific RNA Gene Expression Sequencing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America RNA Gene Expression Sequencing Investment Opportunities and Key Challenges
Table 31. Central and South America RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa RNA Gene Expression Sequencing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa RNA Gene Expression Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina RNA Gene Expression Sequencing SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific RNA Gene Expression Sequencing SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. Bio-Rad Corporation Information
Table 53. Bio-Rad Description and Major Businesses
Table 54. Bio-Rad Product Features and Attributes
Table 55. Bio-Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Bio-Rad Revenue Proportion by Product in 2024
Table 57. Bio-Rad Revenue Proportion by Application in 2024
Table 58. Bio-Rad Revenue Proportion by Geographic Area in 2024
Table 59. Bio-Rad RNA Gene Expression Sequencing SWOT Analysis
Table 60. Bio-Rad Recent Developments
Table 61. Agilent Technologies Corporation Information
Table 62. Agilent Technologies Description and Major Businesses
Table 63. Agilent Technologies Product Features and Attributes
Table 64. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Agilent Technologies Revenue Proportion by Product in 2024
Table 66. Agilent Technologies Revenue Proportion by Application in 2024
Table 67. Agilent Technologies Revenue Proportion by Geographic Area in 2024
Table 68. Agilent Technologies RNA Gene Expression Sequencing SWOT Analysis
Table 69. Agilent Technologies Recent Developments
Table 70. QIAGEN Corporation Information
Table 71. QIAGEN Description and Major Businesses
Table 72. QIAGEN Product Features and Attributes
Table 73. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. QIAGEN Revenue Proportion by Product in 2024
Table 75. QIAGEN Revenue Proportion by Application in 2024
Table 76. QIAGEN Revenue Proportion by Geographic Area in 2024
Table 77. QIAGEN RNA Gene Expression Sequencing SWOT Analysis
Table 78. QIAGEN Recent Developments
Table 79. Roche Corporation Information
Table 80. Roche Description and Major Businesses
Table 81. Roche Product Features and Attributes
Table 82. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Roche Recent Developments
Table 84. Pacific Biosciences Corporation Information
Table 85. Pacific Biosciences Description and Major Businesses
Table 86. Pacific Biosciences Product Features and Attributes
Table 87. Pacific Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Pacific Biosciences Recent Developments
Table 89. Eurofins Scientific Corporation Information
Table 90. Eurofins Scientific Description and Major Businesses
Table 91. Eurofins Scientific Product Features and Attributes
Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Eurofins Scientific Recent Developments
Table 94. Azenta Corporation Information
Table 95. Azenta Description and Major Businesses
Table 96. Azenta Product Features and Attributes
Table 97. Azenta Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Azenta Recent Developments
Table 99. LabCorp Corporation Information
Table 100. LabCorp Description and Major Businesses
Table 101. LabCorp Product Features and Attributes
Table 102. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. LabCorp Recent Developments
Table 104. BGI Genomics Corporation Information
Table 105. BGI Genomics Description and Major Businesses
Table 106. BGI Genomics Product Features and Attributes
Table 107. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. BGI Genomics Recent Developments
Table 109. Zhijiang Biology Corporation Information
Table 110. Zhijiang Biology Description and Major Businesses
Table 111. Zhijiang Biology Product Features and Attributes
Table 112. Zhijiang Biology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Zhijiang Biology Recent Developments
Table 114. Novogene Co., Ltd Corporation Information
Table 115. Novogene Co., Ltd Description and Major Businesses
Table 116. Novogene Co., Ltd Product Features and Attributes
Table 117. Novogene Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Novogene Co., Ltd Recent Developments
Table 119. Macrogen Corporation Information
Table 120. Macrogen Description and Major Businesses
Table 121. Macrogen Product Features and Attributes
Table 122. Macrogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Macrogen Recent Developments
Table 124. Tsingke Biotechnology Co., Ltd. Corporation Information
Table 125. Tsingke Biotechnology Co., Ltd. Description and Major Businesses
Table 126. Tsingke Biotechnology Co., Ltd. Product Features and Attributes
Table 127. Tsingke Biotechnology Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Tsingke Biotechnology Co., Ltd. Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Gene Expression Sequencing Product Picture
Figure 2. Global RNA Gene Expression Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Total RNA Product Picture
Figure 4. Noncoding RNA Product Picture
Figure 5. Global RNA Gene Expression Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Biomedical Field
Figure 7. Non-medical Field
Figure 8. RNA Gene Expression Sequencing Report Years Considered
Figure 9. Global RNA Gene Expression Sequencing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 11. Global RNA Gene Expression Sequencing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global RNA Gene Expression Sequencing Revenue Market Share by Region (2020-2031)
Figure 13. Global RNA Gene Expression Sequencing Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Total RNA Revenue Market Share by Player in 2024
Figure 16. Noncoding RNA Revenue Market Share by Player in 2024
Figure 17. Global RNA Gene Expression Sequencing Revenue Market Share by Type (2020-2031)
Figure 18. Global RNA Gene Expression Sequencing Revenue Market Share by Application (2020-2031)
Figure 19. North America RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
Figure 21. North America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 23. US RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 24. Canada RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 26. Europe RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
Figure 28. Europe RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 31. France RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 33. Italy RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 34. Russia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 40. Japan RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 42. Australia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 43. India RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore RNA Gene Expression Sequencing Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
Figure 51. Central and South America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa RNA Gene Expression Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players RNA Gene Expression Sequencing Revenue (US$ Million) in 2024
Figure 57. South America RNA Gene Expression Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa RNA Gene Expression Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 60. Israel RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa RNA Gene Expression Sequencing Revenue (2020-2025) & (US$ Million)
Figure 63. RNA Gene Expression Sequencing Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
